FCH
BNTX icon

Freestone Capital Holdings’s BioNTech BNTX Stock Holding History

Freestone Capital Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$736K Hold
7,914
– – 0.02% 305
2026
Q1 		$703K Hold
7,914
– – 0.02% 293
2025
Q4 		$753K Buy
+7,914
New +$797K 0.02% 278

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Freestone Capital Holdings's BNTX Position: Q2 2026 in Review

Freestone Capital Holdings held its BioNTech (BNTX) position steady in Q2 2026 at 7,914 shares worth $736K. The position accounts for 0.02% of the portfolio, ranked #305.

Freestone Capital Holdings first reported a position in BNTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $753K in Q4 2025. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Freestone Capital Holdings held 7,914 shares of BioNTech worth $736K as of Q2 2026.
  • Freestone Capital Holdings left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up 0.02% of Freestone Capital Holdings's portfolio in Q2 2026, its #305 holding.
  • Freestone Capital Holdings first reported a position in BioNTech in Q4 2025 and has held it in 3 quarters since.
  • Freestone Capital Holdings's BioNTech position peaked at $753K in Q4 2025.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.